Interpace Diagnostics Group Inc (NASDAQ:IDXG) rose 6.6% on Thursday . The stock traded as high as $1.14 and last traded at $1.13. Approximately 1,184,352 shares changed hands during trading, an increase of 58% from the average daily volume of 751,784 shares. The stock had previously closed at $1.06.
IDXG has been the topic of several research reports. ValuEngine upgraded Interpace Diagnostics Group from a “strong sell” rating to a “sell” rating in a research report on Monday, September 11th. Maxim Group restated a “buy” rating and set a $5.00 price target on shares of Interpace Diagnostics Group in a research report on Tuesday, November 14th.
The stock has a market cap of $30.34, a PE ratio of 0.37 and a beta of 1.60.
WARNING: This story was published by Ticker Report and is owned by of Ticker Report. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/3126158/interpace-diagnostics-group-idxg-stock-price-up-6-6.html.
Interpace Diagnostics Group Company Profile
Interpace Diagnostics Group, Inc, formerly PDI, Inc, is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management.
Receive News & Ratings for Interpace Diagnostics Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Interpace Diagnostics Group and related companies with MarketBeat.com's FREE daily email newsletter.